Avigan, Mark
United States Food and Drug Administration · Center for Drug Evaluation and Research
3 papers on CoChatORCID 0000-0001-5535-7996
Most cited papers
- Verified
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report
Andrade, R. J., Aithal, G. P., de Boer, Y. S., Liberal, R., Gerbes, A., Regev, A., Terziroli Beretta-Piccoli, B., Schramm, C., Kleiner, D. E., De Martin, E., et al. (2023) · Journal of Hepatology
Drug-Induced Hepatotoxicity and ProtectionLiver Diseases and Immunity
Cited by 166
- Verified
Randomized trial of chlorambucil for primary biliary cirrhosis
Hoofnagle, J. H., Davis, G. L., Schafer, D. F., Peters, M., Avigan, M. I., Pappas, S. C., Hanson, R. G., Minuk, G. Y., Dusheiko, G. M., Campbell, G., et al. (1986) · Gastroenterology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 157
- Verified
Lamotrigine and aseptic meningitis
Simms, K. M., Kortepeter, C., & Avigan, M. (2012) · Neurology
Pharmacovigilance and Adverse Drug ReactionsDrug-Induced Adverse Reactions
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free